DK1432407T3 - Lisinoprilpræparater, der har DCPD med store partikler - Google Patents

Lisinoprilpræparater, der har DCPD med store partikler

Info

Publication number
DK1432407T3
DK1432407T3 DK02758654T DK02758654T DK1432407T3 DK 1432407 T3 DK1432407 T3 DK 1432407T3 DK 02758654 T DK02758654 T DK 02758654T DK 02758654 T DK02758654 T DK 02758654T DK 1432407 T3 DK1432407 T3 DK 1432407T3
Authority
DK
Denmark
Prior art keywords
lisinopril
dcpd
preparations
large particles
composition
Prior art date
Application number
DK02758654T
Other languages
Danish (da)
English (en)
Inventor
Ronald John Roberts
David Brandon Bowen
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25505851&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1432407(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Application granted granted Critical
Publication of DK1432407T3 publication Critical patent/DK1432407T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02758654T 2001-09-24 2002-09-20 Lisinoprilpræparater, der har DCPD med store partikler DK1432407T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/962,429 US6462022B1 (en) 2001-09-24 2001-09-24 Lisinopril compositions having large-particle DCPD
PCT/GB2002/004292 WO2003026622A1 (en) 2001-09-24 2002-09-20 Lisinopril compositions having large-particle dcpd

Publications (1)

Publication Number Publication Date
DK1432407T3 true DK1432407T3 (da) 2005-05-23

Family

ID=25505851

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02758654T DK1432407T3 (da) 2001-09-24 2002-09-20 Lisinoprilpræparater, der har DCPD med store partikler

Country Status (10)

Country Link
US (1) US6462022B1 (ja)
EP (1) EP1432407B2 (ja)
JP (1) JP4084749B2 (ja)
AT (1) ATE290370T1 (ja)
DE (1) DE60203192T3 (ja)
DK (1) DK1432407T3 (ja)
ES (1) ES2236561T5 (ja)
GB (1) GB2384429B (ja)
PT (1) PT1432407E (ja)
WO (1) WO2003026622A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196477A1 (en) * 2004-04-30 2007-08-23 Withiam Michael C Rapidly dissolving tablets comprising low surface area calcium phosphates
JP4925835B2 (ja) 2007-01-12 2012-05-09 日東電工株式会社 物質検知センサ
WO2017077425A1 (en) 2015-11-07 2017-05-11 Ftf Pharma Private Limited Oral solution of ace inhibitors
GB2595203A (en) 2020-03-03 2021-11-24 Alkaloid Ad Skopje Formulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US4707361A (en) * 1985-08-02 1987-11-17 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
US4675188A (en) * 1985-08-02 1987-06-23 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
HU222489B1 (hu) † 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra
EP0975285B1 (en) * 1997-04-01 2008-10-01 CAP Biotechnology, Inc. Calcium phosphate microcarriers and microspheres
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets

Also Published As

Publication number Publication date
DE60203192T3 (de) 2012-12-27
GB2384429A (en) 2003-07-30
WO2003026622A1 (en) 2003-04-03
ATE290370T1 (de) 2005-03-15
DE60203192T2 (de) 2006-04-13
GB0311750D0 (en) 2003-06-25
US6462022B1 (en) 2002-10-08
JP2005504803A (ja) 2005-02-17
DE60203192D1 (de) 2005-04-14
EP1432407B1 (en) 2005-03-09
EP1432407B2 (en) 2012-08-01
JP4084749B2 (ja) 2008-04-30
GB2384429B (en) 2004-04-14
EP1432407A1 (en) 2004-06-30
ES2236561T3 (es) 2005-07-16
ES2236561T5 (es) 2012-10-30
PT1432407E (pt) 2005-05-31

Similar Documents

Publication Publication Date Title
HUP0301268A2 (hu) Eljárás porformulációk előállítására
DE59409568D1 (de) Wirkstoffe und gas enthaltende mikropartikel
YU49698A (sh) Smeše koje sadrže tetrahidrolipstatin
HUP0204451A2 (hu) Nimesulidot tartalmazó szabályozott hatóanyag-leadású készítmények
HUP0003095A2 (hu) Tabletta alakú mosószer összesajtolt szemcsékből, valamint eljárás előállítására
BR0003158A (pt) Formulação de dosagem oral de derretimentoinstantâneo
ATE287704T1 (de) Orodispersible tablette mit hoher homogenität und herstellungsverfahren dafür
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
AU8452991A (en) 1-aryl-3-pyridinyl-2-propene-1-ones
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
DK1432407T3 (da) Lisinoprilpræparater, der har DCPD med store partikler
RS51677B (en) PHARMACEUTICAL COMPOSITION COVERING AMLODIPINE BEZILATE AND LISINOPRIL DIHYDRATE AND PROCEDURE FOR THEIR PREPARATION
DE60309472D1 (de) Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant
MD2722B2 (ro) Compoziţie farmaceutică cu carbonat de calciu sau amestecul lui cu hidroxicarbonat de magneziu sau cu vitamina D, utilizată pentru profilaxia sau tratamentul osteoporozei
LV11818A (lv) Jauna farmaceitiska kompozicija stabilas pulverveida zalu formas pagatavosanai
ES2174734A1 (es) Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
ATE357217T1 (de) Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
MXPA05013726A (es) Producto de sucralosa granulada.
AU8452791A (en) 1-phenyl-3-aryl-2-propyne-1-ones
CA2122478A1 (en) Unit Dose Form of Bismuth Subsalicylate
JP2006117544A (ja) 塩酸アンブロキソール含有内服用固形製剤
DE69636983D1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen